AI in pharmaceuticals offers key market opportunities through enhanced diagnostics, early disease detection, clinical trial ...

“Lobular breast cancer tends to spread in a hidden but aggressive way and can come back many years after initial treatment. When it comes back late or in patients at high risk, survival outcomes are ...

With Qassay ® lateral flow readers powered by Artificial Intelligence, it will be possible to detect heart diseases, cancer, diabetes, different viruses, and/or fertility problems The potential of ...

AI applications are a promising solution for PAD that may translate into earlier detection, customized risk assessment, and improved outcomes.

Scientists at the University of Liverpool have developed a new low-cost blood test that could make it easier to detect Alzheimer's disease at an earlier stage—helping patients receive treatment and ...

AI can increase adenoma detection rates by 10-15%, enhancing colonoscopy effectiveness in reducing colorectal cancer risk. Higher adenoma detection rates correlate with lower interval colorectal ...

SpotitEarly, a biotech startup working to transform cancer screening, just released a new study, pointing to the successful results of using both artificial intelligence and canines to detect cancer ...

With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care. CRC ...

Detecting and treating diseases in the chest often presents unique challenges. Because of their concealed but critical location, many conditions, such as lung cancer, remain difficult to detect until ...